Search filters

Filters
Clear All

Phase

  • 1
  • 2
  • 2
  • 5
  • 2
  • 5

Found 5 Ulcerative Colitis trials

A listing of Ulcerative Colitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

99 years or below
All genders
Phase 3
The study will enroll subjects who have completed Study M16-067 or Study M16-065 and have achieved clinical response, defined as decrease from Baseline of induction study of Adapted Mayo score greater than or equal to 2 points and greater than or equal to 30%, PLUS a decrease in rectal bleeding …
99 years or below
All genders
Phase 3
The trial will enroll subjects who have had an inadequate response (IR) to prior biologic therapy (bio-IR). The bio-IR population is defined as subjects with documented intolerance or inadequate response to one or more of the approved biologics for UC (infliximab, adalimumab, golimumab, and/or vedolizumab).
18 years - 75 years
All genders
Interventional
The purpose of this research study is to learn more about the safety and performance of SNS when used in patients who have Crohn’s disease or left-sided ulcerative colitis. The InterStim™ Neurostimulator (InterStim) will be used in every participant who agrees to participate and meets all the eligibility criteria for …
 DECODE Biologic-Describing the Consequences of Delays in Biologic initiation Study
18 years - 99 years
All genders
This study plans to learn more about the usage and effect of biologic medications with patients that have inflammatory bowel disease (IBD). IBD includes both Crohn’s Disease (CD) and Ulcerative Colitis (UC), which currently affects around 1.5 million Americans. Medical therapies for IBD focus on reducing the inflammation of the …
 A OBSERVATIONAL STUDY TO EVALUATE THE ASSOCIATION BETWEEN HISTOLOGICAL REMISSION AND LONG-TERM OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS
18 years - 99 years
All genders
Observational
To evaluate the association between histological remission and a composite outcome of colectomy, IBD-related hospitalization, or intravenous corticosteroid use